These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease. Thomsen TR; Galpern WR; Asante A; Arenovich T; Fox SH Mov Disord; 2007 Nov; 22(15):2268-73. PubMed ID: 17876852 [TBL] [Abstract][Full Text] [Related]
27. Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study. Sockalingam S; Shammi C; Remington G J Clin Psychiatry; 2009 Aug; 70(8):1114-9. PubMed ID: 19758522 [TBL] [Abstract][Full Text] [Related]
28. Intranasal Anticholinergics for Treatment of Chronic Rhinitis: Systematic Review and Meta-Analysis. Pang JC; Vasudev M; Du AT; Nottoli MM; Dang K; Kuan EC Laryngoscope; 2023 Apr; 133(4):722-731. PubMed ID: 35838014 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H; Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [TBL] [Abstract][Full Text] [Related]
30. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Borum P; Olsen L; Winther B; Mygind N Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842 [TBL] [Abstract][Full Text] [Related]
32. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. Ostberg B; Winther B; Borum P; Mygind N Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652 [TBL] [Abstract][Full Text] [Related]
33. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716 [TBL] [Abstract][Full Text] [Related]
34. Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. Wadbo M; Löfdahl CG; Larsson K; Skoogh BE; Tornling G; Arweström E; Bengtsson T; Ström K; Eur Respir J; 2002 Nov; 20(5):1138-46. PubMed ID: 12449166 [TBL] [Abstract][Full Text] [Related]
35. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. Grossman J; Banov C; Boggs P; Bronsky EA; Dockhorn RJ; Druce H; Findlay SR; Georgitis JW; Hampel FC; Kaiser H J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1123-7. PubMed ID: 7538520 [TBL] [Abstract][Full Text] [Related]
36. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Martin RJ; Bartelson BL; Smith P; Hudgel DW; Lewis D; Pohl G; Koker P; Souhrada JF Chest; 1999 May; 115(5):1338-45. PubMed ID: 10334150 [TBL] [Abstract][Full Text] [Related]
37. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492 [TBL] [Abstract][Full Text] [Related]
38. The effect of ipratropium nasal spray on bronchial methacholine challenge. Reid JK; Davis BE; Cockcroft DW Chest; 2005 Sep; 128(3):1245-7. PubMed ID: 16162713 [TBL] [Abstract][Full Text] [Related]
39. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis. Becker B; Borum S; Nielsen K; Mygind N; Borum P Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):132-4. PubMed ID: 9160925 [TBL] [Abstract][Full Text] [Related]